Alasio Teresa M, Sun Wei, Yang Grace C H
Department of Pathology, SUNY Downstate Medical Center, Brooklyn, New York 11203-2098, USA.
Diagn Cytopathol. 2007 Sep;35(9):555-9. doi: 10.1002/dc.20701.
Giant cell carcinoma of the lung is a specific type of lung carcinoma characteristically associated with a highly aggressive clinical behavior. This tumor comprises approximately 1-5% of all lung cancers, affecting a similar patient population as other primary pulmonary carcinomas. It is not routinely treated surgically, owing to the fact that it is metastatic at the time of diagnosis. The cytological diagnosis of this entity on aspiration biopsy has an appreciable impact on patient care. We retrospectively examined 15 cases of lung fine-needle aspirates in which a diagnosis of giant cell carcinoma or large cell carcinoma with giant cell features was made. We applied the criteria for cytological diagnosis of giant cell carcinoma previously set forth in the literature. In cases where there is a tissue diagnosis, we compared the results with the corresponding fine-needle aspirates and correlated them with patient survival. Conclusions are made regarding the reliability of the diagnostic criteria of this malignancy.
肺巨细胞癌是一种特殊类型的肺癌,其特征是具有高度侵袭性的临床行为。该肿瘤约占所有肺癌的1%-5%,与其他原发性肺癌影响相似的患者群体。由于其在诊断时已发生转移,故通常不进行手术治疗。细针穿刺活检对该实体的细胞学诊断对患者护理有显著影响。我们回顾性检查了15例肺细针穿刺病例,这些病例诊断为巨细胞癌或具有巨细胞特征的大细胞癌。我们应用了先前文献中提出的巨细胞癌细胞学诊断标准。在有组织诊断的病例中,我们将结果与相应的细针穿刺物进行比较,并将它们与患者生存率相关联。得出了关于这种恶性肿瘤诊断标准可靠性的结论。